XML 55 R45.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes - Additional Information (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Taxes [Line Items]    
Provision or benefit for income taxes $ 0 $ 0
Income Tax Contingency [Abstract]    
Valuation allowance 16,100,000  
Increase (decrease) in valuation allowance $ 4,600,000  
Net operating loss carryforwards, Expire date begin to expire in 2037  
Cumulative change in ownership 50.00%  
Period of net operating loss and R&D tax credit carry forwards to offset future taxable income 3 years  
Liability for uncertain tax positions $ 0 0
Period for material changes of liability for uncertain tax benefits 12 months  
Interest related to unrecognized tax benefits in interest expense and penalties $ 0  
Deferred tax assets related to NOL carryforwards 12,605,000 10,404,000
Internal Revenue Service (IRS) [Member]    
Income Tax Contingency [Abstract]    
Federal tax carry forward   346,800,000
State tax credit carryforwards   173,000,000.0
Deferred tax assets related to NOL carryforwards   84,900,000
Overstatement of deferred tax assets   8,400,000
Federal [Member]    
Income Tax Contingency [Abstract]    
Tax loss carryforwards 59,600,000  
Federal tax carry forward $ 1,200,000  
Federal tax credit carryforward, Expiration date begin to expire in 2039  
Net operating losses $ 56,200,000  
Federal [Member] | Internal Revenue Service (IRS) [Member]    
Income Tax Contingency [Abstract]    
Research and development credits, overstated   6,000,000.0
Federal [Member] | Maximum [Member]    
Income Tax Contingency [Abstract]    
Percentage of federal net operating losses used to offset of future taxable income 80.00%  
State [Member]    
Income Tax Contingency [Abstract]    
Tax loss carryforwards $ 1,800,000  
State [Member] | Internal Revenue Service (IRS) [Member]    
Income Tax Contingency [Abstract]    
Research and development credits, overstated   $ 5,500,000